Negative Results Prize in Clinical Neuroscience
The Negative Results Prize in Clinical Neuroscience recognises those who have made exceptional contributions to CNS treatment science by publishing clinical research with negative findings. Winners are selected especially on the basis of the impact of their findings in helping the field to optimise its resource and investment allocation and, in doing so, advance long-term treatment development.
The Best Negative Results Prize in Clinical Neuroscience was awarded to C.G. Abdallah et al. for 'Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin' in Neuropsychopharmacology (2020) 45, pp. 990-97.
Extending its previous sponsorship of the Best Negative Data Prize for results in preclinical neuroscience, as of 2021 the U.S.-based non-profit research organisation Cohen Veterans Bioscience (CVB) provided a cash prize of EUR 10,000 to accompany the award.
The winner delivered an award talk presenting the results at the 34th ECNP Congress Hybrid, 2-5 October 2021 in Lisbon, Portugal. More info about session can be found here.
For the full press announcement of the award, click here.
View here previous ECNP Negative Results Prize in Clinical Neuroscience winners.